T J Seng
Overview
Explore the profile of T J Seng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seng T, Currey N, Cooper W, Lee C, Chan C, Horvath L, et al.
Br J Cancer
. 2008 Jul;
99(2):375-82.
PMID: 18594535
The significance of chromosome 3p gene alterations in lung cancer is poorly understood. This study set out to investigate promoter methylation in the deleted in lung and oesophageal cancer 1...
2.
Kohonen-Corish M, Sigglekow N, Susanto J, Chapuis P, Bokey E, Dent O, et al.
Oncogene
. 2007 Jan;
26(30):4435-41.
PMID: 17260021
The mutated in colorectal cancer (MCC) gene is in close linkage with the adenomatous polyposis coli (APC) gene on chromosome 5, in a region of frequent loss of heterozygosity in...
3.
Seng T, Low J, Li H, Cui Y, Goh H, Wong M, et al.
Oncogene
. 2006 Jul;
26(6):934-44.
PMID: 16862168
Identification of tumor suppressor genes (TSG) silenced by methylation uncovers mechanisms of tumorigenesis and identifies new epigenetic tumor markers for early cancer detection. Both nasopharyngeal carcinoma (NPC) and esophageal carcinoma...
4.
Ying J, Li H, Seng T, Langford C, Srivastava G, Tsao S, et al.
Oncogene
. 2005 Oct;
25(7):1070-80.
PMID: 16247458
Protocadherins constitute the largest subgroup in the cadherin superfamily of cell adhesion molecules. Their major functions are poorly understood, although some are implicated in nervous system development. As tumor-specific promoter...
5.
Tai E, Koay E, Chan E, Seng T, Loh L, Sethi S, et al.
Clin Chem
. 2001 Mar;
47(3):438-43.
PMID: 11238294
Background: Familial hypercholesterolemia (FH) and familial defective apolipoprotein B-100 (FDB) represent ligand-receptor disorders that are complementary. Individuals with both FH and FDB are unusual. We report a family with both...